awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38765656-EA56AA1C-960A-456B-B838-DDD49D4C38B2
Q38765656-EA56AA1C-960A-456B-B838-DDD49D4C38B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38765656-EA56AA1C-960A-456B-B838-DDD49D4C38B2
Evaluation of the long-term cost-effectiveness of liraglutide vs lixisenatide for treatment of type 2 diabetes mellitus in the UK setting.
P2860
Q38765656-EA56AA1C-960A-456B-B838-DDD49D4C38B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38765656-EA56AA1C-960A-456B-B838-DDD49D4C38B2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a994cb482064c6ef8c321ff97a557ad4f44e4b3e
P2860
Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus.